Table 3. Serial survival rates according to epidemiological characteristics and treatment method.
| Parameters | 1-year | 2-year | 3-year | 4-year | 5-year | 6-year | 7-year | 8-year | 9-year | 10-year | 11-year | Log-rank P-value | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | 63.4 (63.0–63.9) | 51.7 (51.1–52.0) | 46.2 (45.7–46.7) | 43.2 (42.7–43.7) | 41.0 (40.5–41.5) | 39.4 (38.9–39.9) | 37.9 (37.4–38.4) | 36.8 (36.3–37.3) | 35.7 (35.2–36.2) | 34.8 (34.3–35.4) | 33.8 (33.2–34.4) | < 0.001 | |
| Age, yr | < 0.001 | ||||||||||||
| 0–19 | 88.4 (87.4–89.4) | 81.1 (79.9–82.4) | 78.4 (77.0–79.7) | 76.7 (75.2–78.0) | 75.6 (74.1–76.9) | 74.7 (73.2–76.0) | 73.7 (72.7–75.1) | 73.0 (71.4–74.4) | 72.4 (70.7–73.8) | 72.3 (70.5–73.7) | 72.3 (70.5–73.7) | ||
| 20–39 | 88.4 (87.5–89.2) | 79.7 (78.6–80.7) | 74.7 (73.5–75.9) | 71.8 (70.5–73.0) | 69.2 (67.8–70.4) | 67.1 (65.7–68.4) | 65.0 (63.6–66.4) | 63.7 (62.2–65.1) | 62.0 (60.4–63.4) | 60.6 (58.9–62.0) | 59.2 (57.3–60.7) | ||
| 40–64 | 68.6 (68.0–69.3) | 54.6 (53.8–55.3) | 48.0 (47.3–48.8) | 44.3 (43.6–45.1) | 41.8 (41.0–42.5) | 39.9 (39.1–40.7) | 38.4 (37.5–39.1) | 37.0 (36.1–37.8) | 35.7 (34.9–36.5) | 34.6 (33.7–35.5) | 33.1 (32.1–34.0) | ||
| ≥ 65 | 41.9 (41.1–42.7) | 30.3 (29.5–31.0) | 25.1 (24.4–25.9) | 22.4 (21.7–23.1) | 20.3 (19.6–21.0) | 18.6 (17.9–19.3) | 17.2 (16.4–17.9) | 16.0 (15.3–16.8) | 14.9 (14.1–15.6) | 14.0 (13.2–14.9) | 13.2 (10.9–14.1) | ||
| Sex | < 0.001 | ||||||||||||
| Male | 59.4 (58.8–60.0) | 47.2 (46.5–47.8) | 41.9 (41.3–42.6) | 39.0 (38.3–39.6) | 36.9 (36.2–37.6) | 35.4 (34.7–36.1) | 34.0 (33.3–34.7) | 33.0 (32.3–33.7) | 31.7 (31.0–32.4) | 30.9 (30.1–31.6) | 29.8 (29.0–30.6) | ||
| Female | 67.9 (67.2–68.5) | 56.6 (55.9–57.3) | 51.0 (50.3–51.7) | 48.0 (47.2–48.7) | 45.6 (44.9–46.3) | 43.8 (43.0–44.5) | 42.3 (41.5–43.0) | 41.1 (40.3–41.8) | 40.1 (39.3–40.9) | 39.3 (38.4–40.1) | 38.4 (37.4–39.2) | ||
| Treatment | < 0.001 | ||||||||||||
| No | 54.4 (53.7–55.0) | 47.2 (46.6–47.9) | 43.7 (43.0–44.4) | 41.5 (40.8–42.1) | 39.8 (39.2–40.5) | 38.5 (37.8–39.2) | 37.3 (36.6–38.0) | 36.4 (35.7–37.1) | 35.4 (34.7–36.1) | 34.5 (33.7–35.2) | 33.8 (33.0–34.5) | ||
| TMZ or operation | 73.9 (7.3–74.5) | 56.8 (56.1–57.5) | 49.1 (48.4–49.8) | 45.2 (44.4–45.9) | 42.3 (41.6–43.1) | 40.3 (39.5–41.0) | 38.5 (37.7–39.3) | 37.1 (36.3–37.9) | 35.9 (35.1–36.7) | 35.1 (34.3–36.0) | 33.7 (32.7–34.6) | ||
| TMZ | < 0.001 | ||||||||||||
| No | 62.3 (61.8–62.8) | 54.1 (53.6–54.7) | 49.8 (49.3–50.3) | 47.1 (46.6–47.7) | 45.0 (44.4–45.5) | 43.3 (42.8–43.9) | 41.9 (41.3–42.4) | 40.6 (40.1–41.2) | 39.5 (38.9–40.0) | 38.5 (37.9–39.1) | 37.5 (36.8–38.1) | ||
| Yes | 70.5 (69.3–71.6) | 35.6 (34.3–36.9) | 22.9 (21.8–24.1) | 17.6 (16.5–18.7) | 15.0 (14.0–16.1) | 13.2 (12.2–14.3) | 11.7 (10.7–12.8) | 11.1 (10.1–12.2) | 10.6 (9.5–11.6) | 10.1 (8.9–11.1) | 9.1 (6.9–10.2) | ||
| Operation | < 0.001 | ||||||||||||
| No | 54.4 (53.8–55.1) | 47.0 (46.3–47.6) | 43.4 (42.7–44.0) | 41.1 (40.5–41.8) | 39.5 (38.8–40.1) | 38.1 (37.5–38.8) | 36.9 (36.3–37.6) | 36.0 (35.3–36.7) | 35.0 (34.3–35.7) | 34.1 (33.3–34.8) | 33.4 (32.6–34.1) | ||
| Yes | 74.2 (73.6–74.8) | 57.3 (56.5–58.0) | 49.6 (48.9–50.3) | 45.7 (44.9–46.4) | 42.8 (42.1–43.6) | 40.8 (40.0–41.5) | 39.0 (38.2–39.8) | 37.6 (36.8–38.4) | 36.4 (35.6–37.2) | 35.6 (34.8–36.5) | 34.2 (33.2–35.1) | ||
TMZ = temozolomide.